How China Passed Up a Vaccine Opportunity and Fell Behind – BloombergQuint

(Bloomberg) — The call came early in the Covid-19 pandemic. Drew Weissman, an infectious diseases professor at the University of Pennsylvania and an expert in messenger RNA, received a query from a Chinese company interested in using the new technology to make a vaccine against the coronavirus.
mRNA, which effectively turns the bodys cells into tiny vaccine-making factories, has since become the breakout star of the Covid era, underpinning shots made by Moderna Inc. and the Pfizer Inc./BioNTech…

Click here to view the original article.